Covered recipient · General Payments record
EVAN NADLER
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2018–2024
$54,050.62
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $14,131.25 | 1 |
| Travel and Lodging | $10,200.05 | 3 |
| Food and Beverage | $712.46 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $24,649.26 | 5 |
| Novo Nordisk AS | $394.50 | 5 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | $500.00 | 04/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096552247 | CMS |
| Novo Nordisk AS | $14,131.25 | 04/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096552607 | CMS |
| Novo Nordisk AS | $218.38 | 04/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096552999 | CMS |
| Novo Nordisk AS | $317.96 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096553033 | CMS |
| Novo Nordisk AS | $9,481.67 | 04/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096553311 | CMS |
| Novo Nordisk Inc | $46.19 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096838335 | CMS |
| Novo Nordisk Inc | $124.97 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097452296 | CMS |
| Novo Nordisk Inc | $16.83 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096935591 | CMS |
| Novo Nordisk Inc | $124.13 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097503218 | CMS |
| Novo Nordisk Inc | $82.38 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096994934 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.